Literature DB >> 6133999

Hepatitis B virus infection in two Gambian villages.

H C Whittle, A K Bradley, K McLauchlan, A B Ajdukiewicz, C R Howard, A J Zuckerman, I A McGregor.   

Abstract

The prevalence of hepatitis B virus infection was markedly different in two neighbouring Gambian villages. 62% of children in Manduar aged 2-4 years were infected whereas in Keneba, the other village, only 27% of this age-group were infected. However, in both villages few infants were infected--none under 6 months of age and only 2 of 58 between the ages of 6 and 12 months. Carriage of hepatitis B surface antigen (HBsAg) was high, reaching a peak of 36% in the 5-9 age-group in Manduar and 17.6% in the 2-4 age-group in Keneba. 86% of all the children under the age of five who were HBsAg-positive also carried hepatitis B e antigen (HBeAg). This proportion fell to 17.6% for children aged 10-14 years and to 12.9% for mothers. Infection clustered in families, transmission from sib to sib being of major importance. The chances of a child being an HBsAg carrier were approximately 42% if an elder sib carried the antigen, 27% if either mother or father was a carrier, and 15% if neither mother or father was a carrier. There were 4 HBeAg-positive mothers who were highly infectious, since 10 of 11 of their children became HBsAg carriers. Carriage of surface antigen lasted many years; 63% of those carrying the antigen in 1972 were still positive in late 1980. 4 cases of primary hepatocellular carcinoma out of 672 adults have been diagnosed in the past five years. All 4 were in HBsAg carriers.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6133999     DOI: 10.1016/s0140-6736(83)92477-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  43 in total

1.  Human herpesvirus 8 infection in children and adults in a population-based study in rural Uganda.

Authors:  Lisa M Butler; Willy A Were; Steven Balinandi; Robert Downing; Sheila Dollard; Torsten B Neilands; Sundeep Gupta; George W Rutherford; Jonathan Mermin
Journal:  J Infect Dis       Date:  2011-01-26       Impact factor: 5.226

2.  Sexually transmitted viral infections in various population groups in Mogadishu, Somalia.

Authors:  H Jama; L Grillner; G Biberfeld; S Osman; A Isse; M Abdirahman; S Bygdeman
Journal:  Genitourin Med       Date:  1987-10

Review 3.  Strategies for hepatitis B immunisation.

Authors:  A P Catterall; I M Murray-Lyon
Journal:  Gut       Date:  1992-05       Impact factor: 23.059

4.  Recombination in the genesis and evolution of hepatitis B virus genotypes.

Authors:  Peter Simmonds; Sofie Midgley
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

5.  Familial pattern of infection with hepatitis B virus among immigrating Ethiopian Jews in Israel.

Authors:  N Bisharat; M Elias; R Raz; E Flatau
Journal:  Eur J Epidemiol       Date:  1998-01       Impact factor: 8.082

6.  Hepatitis B in a West Indian population in the United Kingdom.

Authors:  M J Godley; P W Laidler; J E Banatvala
Journal:  Br Med J (Clin Res Ed)       Date:  1986-02-08

Review 7.  Natural history of the HBsAg carrier.

Authors:  M G Anderson; I M Murray-Lyon
Journal:  Gut       Date:  1985-08       Impact factor: 23.059

8.  Observational study of vaccine efficacy 14 years after trial of hepatitis B vaccination in Gambian children.

Authors:  Hilton Whittle; Shabbar Jaffar; Michael Wansbrough; Maimuna Mendy; Uga Dumpis; Andrew Collinson; Andrew Hall
Journal:  BMJ       Date:  2002-09-14

9.  Cellular immunity induced by the recombinant Plasmodium falciparum malaria vaccine, RTS,S/AS02, in semi-immune adults in The Gambia.

Authors:  M Pinder; W H H Reece; M Plebanski; P Akinwunmi; K L Flanagan; E A M Lee; T Doherty; P Milligan; A Jaye; N Tornieporth; R Ballou; K P M J McAdam; J Cohen; A V S Hill
Journal:  Clin Exp Immunol       Date:  2004-02       Impact factor: 4.330

10.  Hepatitis B viral load and risk for liver cirrhosis and hepatocellular carcinoma in The Gambia, West Africa.

Authors:  M E Mendy; T Welzel; O A Lesi; P Hainaut; A J Hall; M H Kuniholm; S McConkey; J J Goedert; S Kaye; S Rowland-Jones; H Whittle; G D Kirk
Journal:  J Viral Hepat       Date:  2009-10-27       Impact factor: 3.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.